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Abstract
Background: evaluation instruments, properties, selection indicators, application and validation of screening
and diagnostic tests. Aim: to present some concepts concerning screening and diagnostic tests and their
application according to a specific purpose. To present a few practical examples of the application of these
instruments related to human communication, as well as to present validation criteria of tests in the
population and criteria used for the rational selection of screening or diagnostic instruments in health
programs and health services based on epidemiological concepts indexed in Scielo, Lilacs or Medline up to
January 2007. Conclusion: diagnostic instruments differ from screening instruments in their objectives and
eligibility criteria. Sensibility and specificity are two important indicators to be considered when choosing
an instrument for screening or diagnosis. Reproducibility, time required to complete the evaluation and
previous preparation of patients, if needed, are also indicators to be considered when choosing an instrument.
Publication and information exchange regarding the properties of evaluation instruments, used for diagnosis
or screening, related to the Speech, Language and Hearing Sciences must be systematically stimulated.
Besides that, improving the knowledge about methodologies and evaluation instruments under different
perspectives contribute to the better use of human and financial resources. Furthermore, the elaboration of
studies that promote the correct validation of screening and diagnostic instruments used in human
communication disorders contributes to the increase in knowledge in the field of Speech, Language and
Hearing Sciences and, indirectly, to the acknowledgement of this science, based on technical-scientific
evidence, in health promotion.
Key Words: Diagnostic; Screening; Sensitivity; Specifity; Evaluation.
Resumo
Tema: instrumentos diagnósticos, propriedades e uso de indicadores para seleção, aplicação e validação de
instrumentos de diagnóstico e de rastreamento. Objetivo: apresentar conceitos ligados aos instrumentos de
avaliação e sua aplicação de acordo com o objetivo, seja rastreamento ou diagnóstico. Também são
apresentados alguns exemplos práticos de aplicação de instrumentos de avaliação ligados à comunicação
humana, bem como critérios de validação de testes na população e critérios utilizados para sua escolha e
aplicação racional em serviços e programas de saúde a partir de pressupostos epidemiológicos pesquisados
em artigos indexados nas bases de dados Scielo, Lilacs ou Medline até janeiro de 2007. Conclusão: instrumentos
de avaliação e diagnóstico clínico diferem dos instrumentos de rastreamento em relação a seus objetivos e
critérios de elegibilidade. São indicativos da precisão de um instrumento de avaliação, seja para rastreamento
ou diagnóstico, a sensibilidade e a especificidade de tal instrumento. Questões como reprodutibilidade, tempo
para realização do teste ou exame e preparação prévia do paciente também devem ser considerados quando
da seleção de instrumentos de avaliação clínica. O conhecimento e disseminação de informações ligadas às
propriedades dos instrumentos de avaliação ligados a Fonoaudiologia devem ser incentivados sistematicamente.
Além disso, a ampliação da gama de conhecimentos acerca das diferentes perspectivas ligadas às metodologias
e instrumentos diagnósticos contribuem com a melhor racionalização de recursos humanos e financeiros. A
elaboração de estudos que promovam a validação dos instrumentos correntemente utilizados para rastreamento
e diagnóstico dos distúrbios da comunicação humana colabora com o avanço do conhecimento ligado a
Fonoaudiologia e, indiretamente, para com o reconhecimento da ciência fonoaudiológica, baseada em
evidências técnico-científicas, na promoção da saúde.
Palavras-Chave: Diagnóstico; Rastreamento; Sensibilidade; Especificidade; Avaliação.
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Introduction
In the last decades, allied to the immense
technological advancement, biosciences has
been developed a lot of knowledge, mainly in
the last few years.  Along with this process,
the role of Speech and Hearing Sciences has
been recognized and research related to the
human communication has been developed
progressively, contributing with a big part of
the knowledge that is used nowadays.  In the
present time, studies that show stronger
sc ien t i f i c  ev idences ,  tha t  b r ing  more
evidences of speech-language and hearing
pathology (SLP) impact in the prevention and
rehabilitation of human communication earns
more space in the SLP research agenda, in
order to be possible earn and maintain SLP
work in the health related teams, contributing
to the integrality of health promotion.
In this sense, is extremely important to
guaran tee  and  ex tend  the  a rguments ,
knowledge and practices that are already
diffused in other areas of knowledge in order
to contribute with the advancement of the
knowledge  re la ted  to  the  eva lua t ion ,
d iagnos i s  and  handl ing  of  human
communication and its related disorders.
It is necessary to think that health workers
commonly use some kind of measure at the
d iagnos t ic  and  /  o r  a t  the  the rapeu t ic
procedures, like the examples referred by
Noble  e t  a l  (2004)  and Gomes (2005) .
Therefore, when researching the clinical
history of the patient or the history of his
complaint we measure the time elapsed since
the beginning of the signs and symptoms, its
variation and intensity in this period, between
others.  Beyond that, the maximum phonation
time measurement, facial thirds measures,
accompaniment of each swallowing stage,
measurement of the auditory sharpness and
speech  d i sorders  eva lua t ion  a re  some
practical examples of measurement use of
tests and instruments in the SLP clinical
approach.
Based in some conceptions, these data
cont r ibu te  to  the  SLP d iagnos i s  and
therapeu t ic  p lann ing ,  cons ider ing  tha t
treatment planning shall be based on more
accurate diagnosis and it all can improve the
success  and  e f fec t iveness  o f  SLP
intervention.
Another example, described by Oliveira et
al (2002), remits us to the deafness diagnosis.
The  au thors  a f f i rm tha t  nowadays  i s
consensual that just medical observation and
the family suspicion are not sufficient for the
detection of deafness in the first year of life.
More truthful evaluation is desirable, based
on standardized instruments such as the
otoacust ic  emiss ions  and BERA (Brain
Electrical Response Audiometry), between
others.
Stands out that more precise knowledge
of evaluation instruments propert ies,  as
screening or  diagnost ic  tes ts ,  exams or
clinical evaluations a link should be made in
order to apply all new technological resources
must be used rationally. This is just as well
that  more and more these technologies are
available in quantity , but their parameters are
not always properly well known as it should
be to decide what type of instrument shall be
used (Krauss-Hisses, 2004; Potvin, 2005).
Decisions about asking for complementary
evaluations and the use of other exams that
vary from low to high complexity should be
harnessed ,  be tween  o thers ,  to  the
characteristics of each test and/or procedure
and their contribution for diagnosis, or even,
bring more subsidies for the therapeutic
planning.
As an example we can use a hypothetical
speech disorder as a complaint in a 6 years
old child. It is well known that such evaluation
can be made by spontaneous speech data
collection and recording using pictures that
represent all of the Brazilian Portuguese
phonemes or even from the emission of the
words by the SLP for subsequent repetition
by the  ch i ld  in  eva lua t ion  (Cas t ro  and
Wertzner, 2006; Goulart and Ferreira, 2006).
In the present time, we have a lot of
instruments in Brazil for screening and/or
d iagnos i s  o f  mos t  o f  communica t ion
disorders. Although, it is necessary that all
of these instruments be validated between
subjects with and without the disorders that
intend to diagnose in order to evaluate with
more  prec i s ion  the  po ten t ia l s  o f  the
instrument that is utilized.  The translation of
the characteristics of the tests and/or exams
of  d iagnos i s  and /or  sc reen ing  can  be
characterized by the measurement of the
sensitivity, specificity and predictive values
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of each approach, test or exam.
This  ar t ic le  presents  some concepts ,
reflections and application of screening tests
and diagnostic instruments in the scope of
human communica t ion  hea l th iness  and
communication disorders.  Beyond that, some
pert inent  points  related to screening or
diagnostic tests and instruments validation,
based on Epidemiologic concepts will be
discussed.
These points will be discussed based in
the  sc ient i f ic  l i tera ture  publ ished unt i l
February 2007 in  Scie lo ,  Li lacs  and/or
Medline.  Bibliographic research used the
MESH or DECS terms: rastreamento, track,
screening, screening tests, screening test,
screening procedures, screening method, test
diagnosis, diagnosis, standardized test, tests
validation, evaluation, sensitivity, specificity,
validity, results reliability, evaluation of
b iomedica l  t echnology,  p romot ion  and
prevention in health, health promotion and
language evaluation.
Characteristics and properties of evaluation
Instruments
Costa et al (2004), Jeckel et al (2005a) and
Hochman et al (2005) refer two distinct
objectives that stand out in the assessment
based on an evaluation instrument in clinical
activit ies or for research: precision and
accuracy.
Accuracy refers  to  the capaci ty  of  a
measure be correct in on average.  When the
measure is not accurate, it is biased.  The
precision, also known as reliability, is the
capacity of a measure to give a very similar
resu l t  (o r  the  same resu l t )  in  repea ted
measurements of a same fact.  Both qualities
are very important and should be assured. If
one of these is  absent,  data (or results)
become useless, therefore it could be not
trustworthy.
Access ing  the  fac t s  regard ing  to
reliability, to the accuracy, the importance rank
of the test for decision-making, test costs,
risks and the acceptability of the instrument
and  i t s  cont r ibu t ion  in  the  hea l th iness
reestablishment or in the adverse effects
caused by the instrument also should be
considered on the decision making to use
these instruments (Newman et al, 2003; Noble
et al, 2004; Potvin, 2005).  Such concepts are
close-related to evidence-based cl inical
practice. These concepts were introduced in
the clinical practices in North America since
the  70 ' s ,  main ly  in  the  Medic ine  and
nowadays  these  a rguments  have  been
highlighted in many discussions related to
speech-language and hearing sciences action
in Brazil (Goulart, 2002b; Goulart e Chiari,
2006).
In this way, when considering clinical
studies or population based surveys findings
to evidence-based decision making in order
to health promotion trough collective actions
or in the clinical setting all methods and other
situation related to the research read shall be
considered. Methods used to select sample
part icipants,  instruments used and their
background, training or abilities needed for
those  who appl ied  the  ins t ruments  o r
protocols used in the study (Potvin, 2005;
Goulart, 2002b).  Also, it is imperative to
remember that only data based on similar
populations can be overstepped and, when
there is an extremely selected sample, with a
lot of exclusion criteria, these subjects may
not represent the population in general .
Those factors can interfere in the results
related to tests, instruments or approaches for
diagnosis or screening that show satisfactory
resu l t s  in  spec ia l ly  des igned  research
settings. So, they may not present similar
answers in other opportunities.
How important an instrument can be to
contribute for the decision-making regarding
the therapeutic planning, including itself the
relation of cost-benefits of the instrument
appl ica t ion ,  the  r i sks  to  which  the
profess ional  and/or  the  pa t ient  wi l l  be
submitted by the use of such instrument and
the acceptability of the procedure by the
patient (and his relatives, when in case) also
should be considered when deciding about
the use of these instruments.  These criteria
are widely described and discussed by the
scientific community since the 70's and more
recen t ly  jo in  in  these  admin is t ra t ive
arguments of the health related sectors, users
of health services and the professionals that
often use such instruments in their routine
(McKinlay and Marceau, 2002; Zuckerman,
2003; Georg et al, 2005).
Krauss -S i lva  (2004)  re fe rs  about
technolog ies  and  procedures  coverage
policies, as well as the elaboration of clinical
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guidelines and health services evaluation and
management are increasingly dependent on
formal technology assessments in developed
countr ies .  Regarding Brazi l ,  th is  s tudy
identified some operational barriers to the
elaboration and utilization of technology
assessment that are related to the adequacy
and availability of relevant data as well as to
the absence of enough trained researchers
and decision-makers.
Krauss-Silva (2004) refer to the health
technology assessment (HTA) concept in for
ass ign those  approaches  used to  se lect
among the existing alternatives, individual
technologies or technological joints for deal
with a similar health related need and/or
problem.  Although more limited, HTA are
a l so  he lpfu l   to  se lec t  t echnolog ica l
assemblies organized as programs (a program
can match  up  to  severa l  assembl ies  of
technologies) to manage different health
related problems, either in the technical phase
of priorities selection and for planning and
management of health services as a evidence-
based critic subsidy to organize clinical
guidelines.
Characteristics and application of screening
and diagnosis instruments
Screening aim is the identification of an
illness or risk factor not already recognized
neither by the patient clinical history, physical
exam, laboratory test or other procedure that
can be applied quickly (Bhopal, 2002; Newman
et  a l ,  2003;  Toscano,  2004) .  Screening
ins t ruments  separa te  people  tha t  a re
apparently well, but have an illness or a risk
factor for a disease of those that do not
present them.
Patients screening in the i l lness pre-
clinical phase is already common in the
medical practice and, actually, screening tests
to detect some diseases are being extended
for  the  popula t ion  in  genera l ,  wi thout
complaints (Georg et al, 2005; Fletcher &
Fletcher, 2006).
However, it is important be conspicuous
that the present recommendations related to
the prevention of illness lead to the sense of
submit  the  popula t ion to  speci f ic  tes ts
accord ing  to  the  p redominance  of
characteristic disturbances related to age
groups,  sex and cl inical  character is t ics
(Bhopal, 2002; Newman et al, 2003; Fletcher &
Fletcher, 2006).
Coutinho et al (2003), Toscano (2004) and
Georg et al (2005) affirm that the application
of screening tests should be done considering
the  p remise  tha t  ea r l i e r  d iagnos i s  can
contribute to better prognostic and earlier
treatment, improving the chances to avoid
comorbities and irreversible symptoms.  These
considerations have been already  made in
some studies published by Fiorindo et al
(2004), Toscano (2004) and Cardoso et al
(2004), related to many specialties related to
health sciences.
Toscano (2004) and Fletcher & Fletcher
(2006) refer that a screening test should detect
most number of cases with the lowest cost
poss ib le ,  beyond  do  no t  cause  adverse
reactions or side effects.  The authors also
consider that there is less benefit between
screening tes ts  i f  they are  compared to
diagnostic tests to plan the treatment and
solve  most  of  the  symptoms.  However,
screening tests must be more secure and have
less  adverse  reac t ions  than  the  cur rent
employed clinical tests.  Its use is translated
in low precision regarding the diagnosis,
considering that diagnostic instruments are
more often specific.
An ideal screening instrument should last
just a few minutes to be carried out, beyond
require a minimum of patient's prior prepare
and do not depend on special pre-schedule,
beyond cause no or minimum discomfort to
the patient or his family (Toscano, 2004;
Fletcher & Fletcher, 2006). Whatever possible
it is recommended to use a cheap screening
test, easy to apply and that causes none or
minimum discomforts and/or trouble to the
patients (Toscano, 2004; Jeckel et al, 2005b).
All of these authors also refer that the results
of a screening test should be valid, reliable
and useful.
Briefly, the validity of an screening or
diagnosis instrument can be measured by its
ability to do what it  propose, categorize
adequately the individuals with "pre-clinical"
symptoms  of a disease as positive test and
those subjects without pre-clinical symptoms
of the i l lness l ike negative test .   These
relations between illness and positive test,
not-i l lness and posit ive test ,  i l lness and
negative test and not-illness and negative test
are express through sensibility, specificity and
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predict ive values  of  the tes ts ,  even for
screening or diagnostic tests (Fletcher &
Fletcher, 2006).
The accuracy of the instrument depends,
not only just of the sensibility or specificity
but, also, it depends on the prevalence of the
illness in the evaluated population using these
instruments.  Rarest the illness is,  more
specific should be the test to be helpful, to
detect the cases (illness people).  However, if
an i l lness  has  a  high prevalence in  the
population tested (taking itself as an example
the diabetes mellitus and the auditory hearing
loss that started after the seventh decade of
life), the test should have high sensibility to
be helpful in the clinical practice, therefore,
otherwise, a negative result will express a false
result.  A good screening test should have
high sensibility to not loose the cases of
illness in the population tested, as well as it
must have high specificity in order to reduce
the number of people with false-positive
results that need subsequent investigation
(Bhopal, 2002; Fletcher & Fletcher, 2006).
Diagnostic instruments are commonly more
accurate and bring more details related to the
disease that they are able to diagnose.  As
much as  the screening instruments ,  the
diagnostic  tests  need to be val id to the
populations to which are destined, including
healthy people with the same characteristics
that the group with a disorder or disease that
i t  is  designed for.   Beyond that ,  on the
occasion of  the decision-making by the
utilization of an instrument for diagnosis
should be considered its cost-benefit relation,
its capacity to add information that contribute
wi th  the  therapeu t ic  p lann ing  and
complement,  if  necessary,  the diagnosis
carried out from the anamnesis and clinical
exam finds.
For the diagnostic instruments actually
contribute with information to others already
given data it is important that they have high
specificity, so, rarely the test will be positive
in the absence of illness.
Krauss -S i lva  (2004)  re fe rs  tha t  the
in te rna t iona l  s tud ies  f requent ly  focus
populations whose cultural, demographic and
genetic characteristics differ of the majority
of the Brazilian population, what is extremely
important  when evaluat ing the  s t ra ight
application of these health technologies in the
Brazilian reality.  The author detaches that
such differences can modify, in a significant
way, important parameters related to the
accuracy, the efficacy and the util i ty or
preference of such instruments according to
the different realities that we have in all the
regions of Brazil. Validity problems of the
instruments measures can influence either the
adhesion to these technologies, as well its
effectiveness in our community.
Characteristics and validation of screening or
diagnostic instruments
 For that a screening or clinical diagnostic
instrument be current used and generate
useful and trustful data it must be submitted
to a validation procedure.
Instruments are validated according to the
population to which they are designed to
(adults, infants, with or without deficiencies),
they should be previously tested to verify the
sensibility and specificity in healthy people
and in those already sick for which such
ins t ruments  a re  des igned  to ,  even  to
diagnostic or screening procedures.
Beyond  tha t ,  s tud ies  fo r  measure
instruments validation should count on re-
evaluation by an instrument for the same
purpose properly already validated or, in case
of impossibility to use an instrument with
these character is t ics ,  the  gold s tandard
should be a  cl inical  evaluat ion with an
expertise.
To estimate the sensibility of an instrument
of measure it is necessary to count on a
number of persons that present the event in
which we are interested (disorder, alteration,
illness) and introduce them in this group.
From this, it is necessary to verify in how
many of these the instrument could detect the
event in study (positive test), as describes
Gomes (2005).
In  th i s  case ,  the  sens ib i l i ty  o f  the
instrument is measured by the proportion of
cases in that the results of the test in study,
when positive, agree with the results of a test
considered for reference (gold standard) and
the specificity is the proportion of cases in
the test, when negative, be in agreement with
the test considered for reference (Gomes,
2005; Hochman et al, 2005; Fletcher & Fletcher,
2006).
Taking the use of a screening instrument
to detect speech disorders in infants from 7
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years and older as an example, called TERDAF
(Tes te  de  Ras t reamento  de  Dis tú rb ios
Articulatórios de Fala), designed and validated
by Goulart (2002a), to which were submitted
200 infants with and without such disorder.
If the test detects speech disorder in 163
infants, the sensibility of the test will be
81.5%, in other words, this is the possibility
of TERDAF to be positive in an infant with a
speech disorder.
The  sens ib i l i ty  o f  a  d iagnos t ic  o r
screening test (or exam) measures the capacity
of this to detect something that exists (Gomes,
2005; Hochman et al, 2005). For example, a
sensitive deafness diagnostic instrument
(considering both together, equipment and
examiner )  i s  the  one  tha t ,  wi th  h igh
probability, detects deafness in a deaf patient.
In this way, an instrument is considered
more sensible when increase the probability
of detection of an event (outcome, disorder
or illness).
The specificity is characterized by the
capaci ty of  an instrument  to  not  detect
nonexistent events (Gomes, 2005; Hochman
et al., 2005).  In case of people with normal
arterial tension, an instrument with high
specificity would detect that the arterial
tension in this group is in the l imits of
normality.  Taking itself an example linked to
the  human communica t ion ,  a  spec i f ic
instrument would not detect voice disorders
in a person without dysphonia.
Regard ing  to  the  spec i f ic i ty,  i t  i s
necessary to submit a certain number of
ind iv idua l s  tha t  do  no t  p resen t  the
characteristic of interest to the instrument in
study to verify how many will present negative
result for the event related to the instrument
in study.
Maintaining the previous example, if we
submit ted  220 chi ldren  wi thout  speech
disorders to TERDAF screening test and
among those  the  re fe r red  ins t rument
presented negative result in 99 of them, to
specificity of the instrument would be 45%.
It means that for each ten children without
speech disorders submitted to the screening
tes t ,  approximate ly  four  would  present
negative result (negative test).
Another thing to be considered concerns
to the cut point of the test, it is related to the
level (or degree) of alteration that, when
detected, turns the test result as positive.
This choice involves a decision between
increase the sensibility of the instrument at
the expense of specificity reduction, or vice
versa.  Nearly all of the researchers should
carefully evaluate the relative importance of
the instrument sensibility and specificity to
establish the most adequate cut point to
define the diagnostic transition.
As general strategy, when the main worry
is to avoid the false-positive result  (for
example, the test result can induce to the
indication of a risky procedure to the patient),
then the cut point should turn to have the
more specificity and if the biggest worry is to
stay away from false-negative result (the test
resu l t  o f  a  pa t ien t  wi th  susp ic ion  of
dysphagia, for example), the cut point should
consider the higher sensibility (Fletcher &
Fletcher, 2006).  The authors say that the ROC
(Receive Operator Caracteristic) Curve is the
best way to establish the cut point, optimizing
the sensibility and specificity of the tests.
To build the ROC Curve the researcher
should select several points or levels of test
alteration (different intensity levels,  for
example) and establish the sensibility and the
specif ici ty in each point .   Following,  a
sensibility graphic is made, based on the
proportion of the false-positive results of the
test.  The ideal test is the one that achieves
the upper left extremity of the graphic.  One
of the advantages of this approach is that the
curves (or graphics) of different tests can be
compared.
Newman et al. (2003) agree that much
better the test, more nearby will be its curve
of the left upper corner of the graphic.  These
authors also remember that the necessary
elements for a diagnostic or screening study
to be considered consistent are subject to
answer three main questions: a) the existence
of independent and blind comparison between
the test in study and the "gold standard test"
that is current used to diagnosis the illness.
Authors describe that the patients sample
should be submitted to the test in study and
the gold standard (of reference test), used as
supply of that the patient has or does not have
the disease that the tests intend to diagnose.
Beyond that the results of a procedure cannot
be already known by the person who applies
or interprets the test that is being compared,
seen that those two elements are essential to
avoid biased interpretations, conscious or
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unconscious,  of  the invest igators .   The
diagnostic test (in study) should be applied
in an appropriate sample of similar patients to
that found in the heath services. The patients
in study should present clinical findings
commonly presented by ones with the disease
in study, as well clinical characteristics related
to the differential diagnosis of the disease.
And, finally, the authors suggest that the
diagnostic test  should be validated in a
second independent group of patients.  The
first study (with the diagnostic test) can
predict the accuracy of the test in study.  To
confirm the test performance it is necessary a
new search, with an independent sample,
when the accuracy can be measured and
checked again.
Whenever is possible, the reference test
should be enough known and, ideally, the
best one that already exist.  Usually this
instrument is called the 'gold standard'.  It can
be an exam of the same kind of the one that is
be ing  s tud ied  or  even  another  type  of
instrument. Using as an example, we can
compare the sensibility and specificity of the
otoacustic emissions (OAE) with the BERA
(Brain Electrical Response Audiometry) to
detect deafness in newborns.
Didac t ica l ly,  we  can  summar ize  the
comparison between an instrument in study
and a gold standard test in a two-by-two table
(or contingencies table), presented in the
table 1.
The  2x2  Table  i s  wide ly  used  in
epidemiological studies and its possibilities
of use related to human communication
research examples were described by Goulart
(2002b).
Therefore, (a + c) is the total of subjects
with positive gold standard, it enclose all the
people that we already know that have the
characteristic (or the disease) in study.  The
sum (b + d) correspond to the group of people
that do not present the characteristic in study.
The cell (a) of the table hold all the people
that have positive results even in the test in
study and in the gold standard, these are also
called the "true positive" group.  In the cell
(b) are allocated those who do not present
the event in study according to the gold
standard and present posit ive test  when
submitted the evaluation by the instrument
in study.  The group in the cell (b) is named
"false positive".
In the same way, we call "false negative"
people arranged in the cell (c) and "true
negative" the group of patients arranged in
the cell (d).
As described by Gomes (2005), sensitivity
is calculated by the reason between the
number of true positive and the total of
positive gold standard test and specificity is
characterized by the reason between the all
those patients with true negative test and all
with negative gold standard test (see the
schema below):
Sensitivity = a / (a + c) Specificity = d / (b + d)
Rel iab i l i ty  o f  d iagnos t ic  and /or  o f
screening tests (instruments) also should be
considered.  This test property is related to
the possibility that the test could be applied
by any professional (or not, according with
i t s  objec t ive)  and  pa t ien ts  in  d i f fe rent
moments allowing to have similar test results.
A reliability decrease can be resultant of
problems with the own instrument, such as
technical application difficulties that occur
when complex procedures demand a special
exper t i se  by  the  examiner  o r  d i f fe ren t
interpretations of the test results.  As an
example, we could refer to worse BERA results
when analyzed by different examiners or
videonasopharyngoscopy changes pre and
post speech-language therapy as an indicator
of velopharyngeal closure improvement.
A paper about evaluation instruments
va l ida t ion  approach  should  br ing  the
re l iab i l i ty  tha t  can  be  expec ted  of  the
instrument.  This description is especially
important when analyzing the instrument
results, mainly, when the instruments demand
some experience of  the examiner,  as  in
videolayngoscopy, videonasopharyngoscopy
or videofluoroscopic analysis.  Thus, it is
possible to confirm the agreement level
between the findings (or analyses) when there
are  divergences  between the  examiners
responsible by the interpretation of such
results.  Reliability level inter and intra-
examiner should be analyzed either, such as
described in the Tinnitus Handicap Inventory
(THI) for the Brazilian Portuguese validation,
carried by Ferreira et al (2005).
When the reliability of an instrument in
study seems to be good, but inter-examiner
disagreement  occurs ,  i t  i s  necessary to
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cons ider  i f  the  couple ,  examiner  and
instrument, are good in order to discriminates
effectively those with and without the disease
in study.  Nevertheless, this instrument can
be helpful in clinical evaluation, therefore, if
the test sensitivity is higher than the inter-
examiner agreement, and there is a high
prevalence of disagreement between inter-
examiners, the instrument persist to be simple
and reliable, but dependent of those who
interpret its results (Jaeschke et al, 1995).  The
authors also describe that if two type of
ins t ruments  o f fe r  s imi la r  answers ,  the
application of the second test will offer very
short or none contribution to the diagnosis
process.  This matter should be considered
when  cons tan t  need  of  resources
rationalization is required, especially in the
contemporary Brazilian society, as previously
discussed (Goulart, 2003; Noble et al, 2004).
Oliveira el al. (2002) discuss that deafness
screening tests for infants at risk is also
controversial ,  mainly regarding  to the
instruments and methods that can be used.  In
this way, while some authors defend the
achievement of otoacustic emissions (OAE)
followed by BERA, others advocate the
utilization of BERA as a first choice test.  The
authors still refer that in any of the situations it
is necessary to pay attention to the continuous
evolution of techniques and knowledge,
therefore new plans and new approaches, as the
Products of Distortion and the automatic BERA,
shortly can assume positions of highlight and,
either, first choice instruments.
Another example close to speech-language
and audiology pathologist action regard to the
evaluation instruments choice is described by
Hage et al. (2004).  The authors mention in this
paper instruments with different characteristics
and objectives to child development evaluation.
They detach that the development scales, which
reflect  the main steps during infanti le
development and have the aim to determine
preschooler specific development level.  From
these, the evolution level of the infant is
obtained through facts related about his/her
development and from the straight observation
of his/her behavior.  Some scales assess
specifically the language development, like the
Early Language Milestone Scale (ELMS) and
Reynell Developmental Language Scale (RDLS),
other evaluate several  aspects of  the
development, among these, Hage et al. (2004)
detach Denver Developmental Screening Test
(DDST) and Escala de Desenvolvimento
Comportamental de Gesell e Amatruda (EDCGA).
Moreira e Ferreira-Junior (2004) carried out
a comparative study between people with
noise- induced hear ing loss  (NIHL) and
ind iv idua ls  wi th  normal  hear ing  and
concluded that  the Percentage Index of
Speech Recognition (PISR) was not helpful in
the diagnosis of NIHL.
Study published by Marteleto e Pedromônico
(2005) established the validity of criteria of the
Inventory of Autistic Behaviors (IAB) and the
authors found that in the sample submitted to
the test, 81.6% of the infants with autism were
correctly identified.  The authors also describe
that the Inventory of Autistic Behaviors (IAB)
showed low sensitivity (57.89%) and high
specificity (94.73%) when the cut point became
68.  When the cut point was diminished to 49
points, the scale sensitivity increased to 92.1%
and the specificity continued on the average
(92.6%).  In this way, the authors suggest that
IAB is a promising instrument for identify autism
in infants, especially with a cut point of 49, also
in the clinical and educational contexts.
A study published by Ferreira et al. in 2005
describe in details  the validation of the
Tinnitus Handicap Inventory (THI) in the
Brazilian population, beyond the application
and results found in the validation of the
instrument in the population researched.
TABLE1. Data disposition in a contingencies table. 
 Gold Standard + Gold Standard  – TOTAL 
Test in Study + a b a + b 
Test in Study – c d c + d 
TOTAL a + c b + d N = a + b + c + d 
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Conclusion
Deeply knowledge about speech-language
and hearing needs in the different population
strata (age group, sex and others, according to
specific disorders related to these variables) is
vital to improve the effectiveness of efforts,
financial and human resources and come,
whenever possible to develop collective health.
Therefore, as it was described by Krauss-Silva
(2003) the chronic incipiencies of activities and
application of the health technologies evaluation
have been visible enough and expressed in the
financial policy and procedures coverage, either
by the public health or in the roll of procedures
of the supplementary health (health insurance).
Then, for that the speech-language and
audiology therapy extends its insertions in the
health related services it is necessary that more
and more all of the professionals have knowledge
and be able to use the available tools for
evidence-based actions.
But, for that that occur, research centers
and univers i t ies  should  s t i l l  contr ibute
strongly to the validation and enlargement of
knowledge about  the appl icat ion of  the
available technologies related to the human
communication.
Beyond that, knowledge production should
be added , as much as possible, to broad
disclosure in scientific communication vehicles,
meetings and journals also to speech-language
pathologists,  audiologists and undergrad
students  through the enclosure of  these
subjects in the pedagogical projects of under
and post graduation programs, as already
occurs in many scientific areas.
The importance of take into account the
tested population sample for instruments
va l ida t ion  concern ing  the  human
communica t ion  should  cons ider  the
reg iona l i sms  regard ing  the  speech  and
language  eva lua t ion ;  age  group  and
occupation or professional activity regarding
voice or orofacial motricity assessment,
between others.  In this way, comprehensive
description of the examined population and
the criteria employed for the diagnosis in an
ins t rument  va l ida t ion  research  a re
fundamental to the professional that will use
the instrument or test in the clinical setting or
in another research. Satisfactory instruments
validation and knowledge of its technical
properties in the Brazilian population also can
add more subsidies to the priorities selection
and delineation of the health related programs
content by the decision-makers in different
levels of management.
On the  same way,  when most  of  the
epidemiological details of the population that
need speech-language and audiology care are
known, and their different ways of care needs
based on regional realities,  efficacy, cost-
effectiveness, cost-benefit, as well systematic
reviews would be necessary. And to carry on
these type of studies, it would be necessary to
combine many studies,  but  with similar
methodology.  Such studies can give more
consistent evidences for the advancement of
speech-language and audiology action, from
the progress of the science regarding to the
human communication.
Although, it is necessary to consider that
neither all of the health related disorders, even
connected to the human communication are
subject to prevention and that only the opinion
of speech-language and audiology services
users do not constitute sufficient, neither
satisfactory evidences based on the scientific
and methodological point of view for the
decision-making about the technologies and
resources that would be employed in the
speech-language and audiology care.
Garber (2001) and Krauss-Silva (2004)
mention some studies about the irrational use
of technologies and procedures based on the
users' point of view. These studies show some
evidences about technological use without
ev idence  of  benef i t  and  v ice  versa ,
technology use in adverse conditions, when
efficacy or accuracy can be not the same and
different application of technologies without
the corresponding variation to have better
resu l t s .   They  a l so  descr ibe  the  b ig
fascination exercised by new technologies,
not always better and nearly always more
expensive, beyond commonly complementary
or similar to the ones that already exist.
It is important that the speech-language
therapist and audiologist is aware of these
questions and, whenever necessary, search
for subsidies that can contribute with strong
evidences to decisions taken about the use
of tools and instruments in their work.
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